FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Activated Insights Announces 2025 Customer Experience Award™ Winners, Recognizing Excellence in Long-Term and Post-Acute Care
Activated Insights, the leading provider of training, recruitment, retention, experience management and recognition tools to ...
China’s influence on Panama Canal poses ‘acute risks to US national security,’ Sen. Cruz warns
China's influence on the Panama Canal is a major risk to U.S. national security, Sen. Ted Cruz told lawmakers during a Senate ...
Israel tells UN it's shutting down all UNRWA operations in Jerusalem: 'acute security risks'
Israel demands UNRWA halt operations in Jerusalem by January 30, citing Hamas ties and security risks. The move follows ...
FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years
The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for moderate to ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
FDA approves Vertex's first-in-class non-opioid analgesic for acute pain
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) ...
Cure Today2h
Galinpepimut-S Immunotherapy Has Preliminary Efficacy in Acute Myeloid Leukemia
Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...
Funding announcement for RVH will see acute care and complex continuing care units upgraded
Calling it a “game changer” for Renfrew Victoria Hospital (RVH), Renfrew-Nipissing-Pembroke MPP John Yakabuski said the ...